1-20 of 22
Kaiqi Liu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Olverembatinib Combined with Venetoclax and Reduced-Intensity Chemotherapy for Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Early Results from a Phase II Study

Xiaoyuan Gong, Qiuyun Fang, Runxia Gu, Shaowei Qiu, Kaiqi Liu, Dong Lin, Chunlin Zhou, Guangji Zhang, Benfa Gong, Yuntao Liu, Shuning Wei, Yan Li, Shouyun Li, Bingcheng Liu, Yimin Hu, Junfan Li, Ying Wang, Hui Wei, Yingchang Mi, Jianxiang Wang
Journal: Blood
Blood (2023) 142 (Supplement 1): 827.
https://doi.org/10.1182/blood-2023-184421
Published: 2023
Journal Articles

Venetoclax Combined with Daunorubicin and Cytarabine (2 + 6) in Acute Myeloid Leukemia: Updated Results of a Phase II Trial

Xiaohui Suo, Dongmei Wang, Fang Zheng, Suping Zhang, Congcong Zhang, Yinling Li, Rui Shi, Yan Wu, Sisi Yang, Liyun Zhao, Zongjiu Jiao, Jie Liu, Ling Zhang, Ling Li, Zhihua Zhang, Xinxiao Lu, Linyu Yuan, Sifeng Gao, Jilei Zhang, Xingli Zhao, Guanchen Bai, Yingchang Mi, Kaiqi Liu
Journal: Blood
Blood (2023) 142 (Supplement 1): 969.
https://doi.org/10.1182/blood-2023-179205
Published: 2023
Journal Articles

Venetoclax Combining with Homoharringtonine，Daunorubicin and Cytarabine (HAD) As Induction Treatment in Newly Diagnosed Adult Acute Myeloid Leukemia Patients

Zhangsong Yan, Yang Li, Bin Zhang, Jinsong He, Jiesi Li, Shuning Wei, Qi Wang, Qiuling Li, Bo Hu, Kaiqi Liu, Yingchang Mi
Journal: Blood
Blood (2023) 142 (Supplement 1): 2895.
https://doi.org/10.1182/blood-2023-179087
Published: 2023
Journal Articles

Venetoclax Combined with Homoharringtonine and Cytarabine ( HAV) As Induction Treatment in Elder or Intensive Chemotherapy (IC) Ineligible Patients with Newly Diagnosed Acute Myeloid Leukemia

Kaiqi Liu, Xiaohui Suo, Guanchen Bai, Zhangsong Yan, Yang Li, Bin Zhang, Jinsong He, Jiesi Li, Shuning Wei, Qiuling Li, Bo Hu, Yingchang Mi
Journal: Blood
Blood (2023) 142 (Supplement 1): 4272.
https://doi.org/10.1182/blood-2023-179009
Published: 2023
Journal Articles

RTK-RAS Signaling Pathway Was Enriched in Rare Acute Myeloid Leukemia Patients with t(16;21)(p11;q22)/ FUS::ERG

Anli Lai, Hui Wei, Ying Wang, Dong Lin, Chunlin Zhou, Bingcheng Liu, Runxia Gu, Yan Li, Shuning Wei, Benfa Gong, Kaiqi Liu, Xiaoyuan Gong, Yuntao Liu, Guangji Zhang, Junping Zhang, Yingchang Mi, Shaowei Qiu, Jianxiang Wang
Journal: Blood
Blood (2023) 142 (Supplement 1): 5988.
https://doi.org/10.1182/blood-2023-179966
Published: 2023
Journal Articles

Integrative Multi-Omic Analysis for Prognosis Stratification in Acute Myeloid Leukemia

Yang Song, Zhe Wang, Guangji Zhang, Jiangxue Hou, Kaiqi Liu, Shuning Wei, Chunlin Zhou, Dong Lin, Min Wang, Jianxiang Wang, Tao Cheng, Yingchang Mi
Journal: Blood
Blood (2023) 142 (Supplement 1): 5984.
https://doi.org/10.1182/blood-2023-173211
Published: 2023
Journal Articles

Venetoclax Combined with Homoharringtonine,Cytarabine and Aclacinomycin (HAAV) As Induction Therapy in Newly Diagnosed Young Adult Acute Myeloid Leukemia

Zepin Zhou, Xingli Zhao, Xiaohui Suo, Guanchen Bai, Zeyan Shi, Yunya Luo, Yaxian Tan, Xinxiao Lu, Linyu Yuan, Congcong Zhang, Yinling Li, Sifeng Gao, Jilei Zhang, Heng Li, Weihua Zhao, Hongling Peng, Pengxiang Guo, Yingchang Mi, Kaiqi Liu
Journal: Blood
Blood (2023) 142 (Supplement 1): 1517.
https://doi.org/10.1182/blood-2023-179275
Published: 2023
Journal Articles

The Impact of ZNF384 Rearranged on Antigen Editing during Treatment-Specific Selective Pressures in Adult B Cell Acute Lymphoid Leukemia

Runxia Gu, Wenbin Liu, Yihan Mei, Le Li, Chunlin Zhou, Yan Li, Yuntao Liu, Shuning Wei, Dong Lin, Kaiqi Liu, Qiuyun Fang, Xiaoyuan Gong, Benfa Gong, Shaowei Qiu, Bingcheng Liu, Yingchang Mi, Hui Wei, Ying Wang, Jianxiang Wang
Journal: Blood
Blood (2023) 142 (Supplement 1): 4209.
https://doi.org/10.1182/blood-2023-188950
Published: 2023
Journal Articles

Prognostic Value of MRD By Flow Cytometry in Adolescent and Adult Patients with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia Treated with Pediatric-Inspired Regimen: A Post-Hoc Analysis from a Prospective Study of China

Xiaoyuan Gong, Qiuyun Fang, Runxia Gu, Shaowei Qiu, Kaiqi Liu, Dong Lin, Chunlin Zhou, Guangji Zhang, Benfa Gong, Yuntao Liu, Yan Li, Shouyun Li, Bingcheng Liu, Ying Wang, Hui Wei, Yingchang Mi, Jianxiang Wang
Journal: Blood
Blood (2023) 142 (Supplement 1): 6073.
https://doi.org/10.1182/blood-2023-174856
Published: 2023
Journal Articles

Three-Day Decitabine Combined with Venetoclax in Patients with Newly Diagnosed or Relapsed/Refractory AML

Xiaohui Suo, Guanchen Bai, Xingli Zhao, Congcong Zhang, Yinling Li, Sifeng Gao, Jilei Zhang, Xinxiao Lu, Linyu Yuan, Yingchang Mi, Kaiqi Liu
Journal: Blood
Blood (2023) 142 (Supplement 1): 5942.
https://doi.org/10.1182/blood-2023-181804
Published: 2023
Journal Articles

Maintenance Therapy with Combination of Azacitidine, Danazol and Thalidomide after Intensive Chemotherapy in Acute Myeloid Leukemia Patients

Fang Zheng, Qianqian Li, Sisi Yang, Zhen Zhou, Qingfan Zeng, Yingchang Mi, Kaiqi Liu
Journal: Blood
Blood (2022) 140 (Supplement 1): 11720–11722.
https://doi.org/10.1182/blood-2022-164675
Published: 2022
Journal Articles

Prognostic Effect and Clinical Application of Early Measurable Residual Disease (MRD) By Flow Cytometry on De Novo Acute Myeloid Leukemia (AML)

Congxiao Zhang, Runxia Gu, Chunlin Zhou, Yan Li, Yuntao Liu, Shuning Wei, Dong Lin, Benfa Gong, Kaiqi Liu, Qiuyun Fang, Xiaoyuan Gong, Shaowei Qiu, Bingcheng Liu, Ying Wang, Hui Wei, Yingchang Mi, Jianxiang Wang
Journal: Blood
Blood (2022) 140 (Supplement 1): 2030–2032.
https://doi.org/10.1182/blood-2022-162459
Published: 2022
Journal Articles

Clinical, Cytogenetic Characteristics and Survival of Acute Leukemia in a National Research Center Database, 10-Year Real-World Data Review

Yan Li, Junping Zhang, Hui Wei, Ying Wang, Bingcheng Liu, Dong Lin, Chunlin Zhou, Kaiqi Liu, Benfa Gong, Shuning Wei, Guangji Zhang, Yuntao Liu, Xiaoyuan Gong, Shaowei Qiu, Runxia Gu, Qiuyun Fang, Jingjing Jin, Zhulin Ma, Xuan Liang, Yingchang Mi, Jianxiang Wang
Journal: Blood
Blood (2021) 138 (Supplement 1): 3062.
https://doi.org/10.1182/blood-2021-148412
Published: 2021
Journal Articles

CD19 CAR-T Cells Treatment Conferred a Sustained Remission in Patients with Chemotherapy-Refractory MRD in B-ALL

Wenyi Lu, MD, Yunxiong Wei, Yaqing Cao, Xia Xiao, MD, Qing Li, Hairong Lyu, Yili Jiang, Huan Zhang, Jia Wang, Xin Li, Yanyu Jiang, Meng Juanxia, Yuan Ting, Haibo Zhu, Xiaoyuan He, Xin Jin, Rui Sun, Tao Sui, Kaiqi Liu, Mingfeng Zhao, MDPhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 48.
https://doi.org/10.1182/blood-2020-140431
Published: 2020
Journal Articles

Phase 1 Results of CNCT19: CD19 CAR Constructed of a New Anti-CD19 Chimeric Antigen Receptor in Relapsed or Refractory Acute Lymphoblastic Leukemia

Runxia Gu, Fang Liu, Dehui Zou, MD, Bingcheng Liu, Wei Liu, Xiaojuan Chen, MD, Kaiqi Liu, Ye Guo, MD, Xiaoyuan Gong, Rui Lv, Xia Chen, Chunlin Zhou, Mengjun Zhong, Yingxi Xu, Huijun Wang, Hui Wei, MD, Yingchang Mi, MD, Lugui Qiu, MD PhD, Lulu Lv, Min Wang, MD, Ying Wang, MD, Xiaofan Zhu, MD, Jianxiang Wang, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2622.
https://doi.org/10.1182/blood-2019-125342
Published: 2019
Journal Articles

The Intermediate Dose Verse Conventional Dose Cytarabine in Induction Therapy in Adult Acute Myeloid Leukemia: A Phase Ⅲ Randomized Controlled Trial

Hui Wei, MD, Ying Wang, MD, Dong Lin, MD, Chunlin Zhou, Bingcheng Liu, MD, Shaowei Qiu, MD, Benfa Gong, Kaiqi Liu, Guangji Zhang, Shuning Wei, Xiaoyuan Gong, Yuntao Liu, Yan Li, MD, Yingchang Mi, MD, Jianxiang Wang, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 146.
https://doi.org/10.1182/blood.V130.Suppl_1.146.146
Published: 2017
Journal Articles

MRD Is an Independent Prognostic Factor in Acute Myeloid Leukemia Carrying t(8;21) Chromosomal Abnormalities

Hui Wei, MD PhD, Ying Wang, MD, Dong Lin, MD PhD, Chunlin Zhou, MD PhD, Bingcheng Liu, Shaowei Qiu, Benfa Gong, Guangji Zhang, Kaiqi Liu, Shuning Wei, Xiaoyuan Gong, MD, Yuntao Liu, Yan Li, MD, Runxia Gu, MD PhD, Yingchang Mi, MD PhD, Jianxiang Wang, MD
Journal: Blood
Blood (2016) 128 (22): 1672.
https://doi.org/10.1182/blood.V128.22.1672.1672
Published: 2016
Journal Articles

Clinical Characteristics and Factors of the Impact on the Survival in 133 De Novo FLT3-ITD Acute Myeloid Leukemia with Intermediate Chromosome Karyoptye from a Single Center of China

Shaowei Qiu, MD, Dong Lin, MD PhD, Hui Wei, MD PhD, Guangji Zhang, Chunlin Zhou, MD PhD, Kaiqi Liu, Shuning Wei, Ying Wang, MD, Bingcheng Liu, Benfa Gong, Xiaoyuan Gong, MD, Yuntao Liu, Yingchang Mi, MD PhD, Jianxiang Wang, MD
Journal: Blood
Blood (2016) 128 (22): 5240.
https://doi.org/10.1182/blood.V128.22.5240.5240
Published: 2016
Journal Articles

Clinical Significance of Myeloblasts Percentage in the De Novo Acute Myeloid Leukemia with Erythroid Hyperplasia

Shaowei Qiu, MD, Hui Wei, MD PhD, Dong Lin, MD PhD, Guangji Zhang, Shuning Wei, Chunlin Zhou, MD PhD, Kaiqi Liu, Ying Wang, MD, Bingcheng Liu, Yuntao Liu, Benfa Gong, Xiaoyuan Gong, MD, Sizhou Feng, Yingchang Mi, MD PhD, Mingzhe Han, Jianxiang Wang, MD
Journal: Blood
Blood (2016) 128 (22): 5245.
https://doi.org/10.1182/blood.V128.22.5245.5245
Published: 2016
Journal Articles

Impact of Additional Chromosomal Abnormalities in Philadelphia-Positive Clone on Prognosis of CML Patients Treated with Tyrosine Kinase Inhibitors

Bingcheng Liu, Ying Wang, MD, Hui Wei, MD PhD, Kaiqi Liu, Dong Lin, MD PhD, Chunlin Zhou, MD PhD, Yingchang Mi, MD, PhD, Jianxiang Wang, MD
Journal: Blood
Blood (2016) 128 (22): 1926.
https://doi.org/10.1182/blood.V128.22.1926.1926
Published: 2016